Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00052286 · ClinicalTrials.gov registry record · NA
Modafinil in Treating Fatigue and Behavioral Change in Patients With Primary Brain Cancer
A NA study, sponsored by Jonsson Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT00052286 is a NA study that has completed, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 29 participants.
The verdict
NCT00052286, a NA study, has completed, sponsored by Jonsson Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
RATIONALE: Modafinil may be effective in relieving fatigue and improving behavioral changes such as memory loss in patients who have undergone treatment for primary brain cancer. The effectiveness of modafinil in relieving fatigue and improving behavioral change is not yet known. PURPOSE: This randomized clinical trial is comparing how well two different doses of modafinil work in treating fatigue and behavioral changes in patients who have undergone treatment for primary brain cancer.
Interventions
- DRUG modafinil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2002-09 |
| Est. Completion | 2010-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00052286
The ClinicalTrials.gov registry entry for NCT00052286 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jonsson Comprehensive Cancer Center, which has 321 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which modafinil is the first listed.
NCT00052286 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00052286 about?
NCT00052286 is a clinical study titled "Modafinil in Treating Fatigue and Behavioral Change in Patients With Primary Brain Cancer". RATIONALE: Modafinil may be effective in relieving fatigue and improving behavioral changes such as memory loss in patients who have undergone treatment for primary brain cancer. The effectiveness of modafinil in relieving fatigue and improving behavioral change is not yet known. PURPOSE: This rand...
What is the current status of trial NCT00052286?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2002-09. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00052286?
The interventions under investigation include: modafinil (DRUG).
Who is sponsoring clinical trial NCT00052286?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.